Voice your opinion on congressional bill S146-118 and let lawmakers know your stance with UnPac!

Cap Insulin Prices Act

This bill reduces cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $25 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply insulin products at $25 beginning in 2024. The current cap on insulin products under Medicare is $35 per month.

Senate Actions

Committee
Jun. 12 2024	Committee on Banking, Housing, and Urban Affairs. Hearings held.

IntroReferral
Jan. 30 2023	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
Jan. 30 2023	Introduced in Senate

Senate bill S146-118

Cap Insulin Prices Act

Promote the cause!

Or use this QR code